Additional file 1 of Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study

MLA

Longato, Enrico, et al. Additional File 1 of Cardiovascular Outcomes after Initiating GLP-1 Receptor Agonist or Basal Insulin for the Routine Treatment of Type 2 Diabetes: A Region-Wide Retrospective Study. Jan. 2021. EBSCOhost, https://doi.org/10.6084/m9.figshare.17007077.

APA

Longato, E., Di Camillo, B., Sparacino, G., Tramontan, L., Avogaro, A., & Fadini, G. P. (2021). Additional file 1 of Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study. https://doi.org/10.6084/m9.figshare.17007077

Chicago

Longato, Enrico, Barbara Di Camillo, Giovanni Sparacino, Lara Tramontan, Angelo Avogaro, and Gian Paolo Fadini. 2021. “Additional File 1 of Cardiovascular Outcomes after Initiating GLP-1 Receptor Agonist or Basal Insulin for the Routine Treatment of Type 2 Diabetes: A Region-Wide Retrospective Study,” January. doi:10.6084/m9.figshare.17007077.